Pharmafile Logo

Webinar: Understanding the Patient Journey in China 2015

January 6, 2016 | Chinese Healthcare, Patient journey 

Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and consider the possible implications for market researchers.

As the affluent middle-class continues to grow and healthcare reforms look set to affect the way that patients access treatment, the Chinese healthcare market is experiencing a period of great change. 

Most recently there are concerns that the devaluation in China’s currency has impacted significantly on the local healthcare demand and that the much publicised healthcare reforms that were due to take effect this year have stalled in the implementation. 

Now more than ever, the researcher needs to ensure that they have a full understanding of how these developments will impact the market.

Register now for the latest in our China webinar series where, utilising local knowledge and detailed case studies, we will examine the current Chinese healthcare market, discuss the likely impact of the Government’s healthcare reforms on the patient journey and consider the possible implication for market researchers.

Our Emerging Markets experts Marc Yates and Rachel Howard will also be considering the impact of China’s more recent financial challenges including the lack of growth within the private sector.

Gain answers to your key questions:

  • Gain a deeper understanding of the changing patient journey in China
  • Identify the opportunities and challenges associated with the healthcare reforms 
  • Learn how to ensure that your market research in China continues to answer the business objectives

To view the webinar please visit: bit.ly/1O05iUJ

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Forever Angels founder is awarded an MBE

We are delighted to announce that Forever Angels founder Amy Hathaway has been awarded an MBE in this year’s Queen’s Birthday Honours list for providing interim and community care to...

Research Partnership’s Singapore team relocates to new office

We are delighted to announce that our Asia-Pacific team in Singapore has relocated to new premises.

Nutrition Market in Brazil: Growth Against the Odds

Published in eyeforpharma June 2017 by Marc Yates

Research Partnership launches new patient Living with Ulcerative Colitis (UC) US report

Living with Ulcerative Colitis (UC) is a study conducted amongst 100 adult UC patients in the US. The study employs a mixed quantitative/qualitative methodology and will be available to purchase...

Research Partnership is celebrating 20 years in business

Watch our short video to see how we have grown. Please note the video comes with some fun, themed music. https://www.researchpartnership.com/news/2017/06/research-partnership-is-celebrating-20-years-in-bus...

Therapy Watch expands oncology and IBD portfolios

This month Therapy Watch expands its portfolio with the launch of several new trackers across numerous therapy areas including the launch of a new Chronic Myelogenous Leukaemia (CML) study in...

Research Partnership announces several new appointments

Research Partnership is delighted to welcome Anne Cunningham and Morten Andersen and announce that Sue Rees has joined our specialist Emerging Markets team.

PMRC San Francisco 2017

We are delighted to be presenting a paper and exhibiting at the Pharmaceutical Market Research Conference 13-14 June in Bay Area close to our new office in San Francisco.Representing Research...

EphMRA Annual Conference 2017

Visit us on stand number 14

Richard Head nominated for EphMRA Award

We are delighted to announce that Research Partnership’s Director Richard Head has been nominated for The EphMRA President’s Award for Contribution to Pharmaceutical Market Research.According to EphMRA, Richard has been...